Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Mar. 02, 2024	Mar. 04, 2023
Cash Flows from Operating Activities:
Net earnings	$ 73.6	$ 46.0
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	111.6	115.9
Stock-based compensation	17.1	15.7
Amortization of deferred financing costs	3.5	3.5
Loss on sale of equity method investment	0.4	0.0
Deferred taxes	(0.3)	(1.2)
Restructuring expense	8.7	19.8
Impairment	0.0	36.6
Decrease in current assets	100.0	5.9
(Decrease) in current liabilities	(32.9)	(159.1)
(Decrease) in non-current liabilities	(2.1)	(5.3)
Other, net	(5.7)	(7.4)
Net Cash Provided by Operating Activities	273.9	70.4
Cash Flows from Investing Activities:
Advances of notes receivable	(10.6)	(4.4)
Proceeds from the sale of equity method investment	3.5	0.0
Capital expenditures	(56.5)	(60.6)
Proceeds from loan on cash surrender value of life insurance	0.0	13.5
Other, net	2.6	(1.7)
Net Cash Used in Investing Activities	(61.0)	(53.2)
Cash Flows from Financing Activities:
Repayments of long-term debt	(22.2)	(19.7)
Proceeds from credit facility	620.1	720.2
Repayments of credit facility	(668.9)	(664.7)
Dividends paid	(42.2)	(42.9)
Common stock issued	4.3	4.5
Common stock repurchased and retired	(101.0)	(15.9)
Other, net	(3.2)	(3.6)
Net Cash Used in Financing Activities	(213.1)	(22.1)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.3	(8.3)
Net Increase (Decrease) in Cash and Cash Equivalents	0.1	(13.2)
Cash and Cash Equivalents, Beginning of Period	223.5	230.3
Cash and Cash Equivalents, End of Period	$ 223.6	$ 217.1